---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-24-000103"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:20:54.394128+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Pacira's EXPAREL patent invalidated by New Jersey court; company plans appeal

## Summary
- U.S. District Court for D.N.J. ruled Pacira's U.S. Patent No. 11,033,495 for EXPAREL is invalid.
- Company intends to appeal the decision to the U.S. Court of Appeals for the Federal Circuit.
- Three separate infringement suits against eVenus remain ongoing; additional patents pending.
- CEO Frank D. Lee stated belief in patent strength and that EXPAREL franchise is well protected.

## SEC filing metadata
- accession: 0001396814-24-000103
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/0001396814-24-000103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/pcrx-20240809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-24-000103
- JSON: https://secwatch.observer/filing/0001396814-24-000103.json
- Plain text: https://secwatch.observer/filing/0001396814-24-000103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.